Comparison of the efficacy and adverse effects of long pulsed 1064 nm Nd: YAG laser and sclerotherapy in the treatment of pyogenic granuloma in children: a retrospective study.

Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

Original Publication: London : Nature Publishing Group, copyright 2011-

Sclerotherapy*/methods ; Sclerotherapy*/adverse effects ; Granuloma, Pyogenic*/therapy ; Lasers, Solid-State*/therapeutic use ; Lasers, Solid-State*/adverse effects; Humans ; Female ; Male ; Retrospective Studies ; Child ; Child, Preschool ; Treatment Outcome ; Adolescent ; Infant

Pyogenic granuloma (PG) is benign vascular lesions of the skin and mucous membranes that often involve the skin and mucous membranes, which often trouble patients due to its frequent bleeding. The traditional treatment is surgical removal, but its bleeding, pain, and trauma have led doctors to look for more minimally invasive methods. Between June 1, 2022 to March 1, 2024, we retrospectively analyzed 72 children with PG who were seen and treated in our department for long pulsed 1064 nm Nd: YAG laser (Gentle Nd: YAG laser) and sclerotherapy, respectively. The efficacy of the two treatments, pain scores, duration of surgery, and adverse events were assessed. The results showed no significant difference between the two groups in the efficacy of first treatment and the efficacy of secondary treatment. Although the procedure time was shorter in Gentle Nd: YAG laser group than in sclerotherapy group, the pain was more pronounced and the incidence of scarring was higher. No significant recurrence was detected in either group during the 6-month follow-up period. Gentle Nd: YAG laser and sclerotherapy for PG are sensitive, less invasive, and safe treatments. Sclerotherapy may be more acceptable to patients than Gentle Nd: YAG laser therapy because it is less painful and scarring is rare.
Competing Interests: Competing interests: The authors declare no competing interests. Ethical approval: This study was conducted under the auspices of our Department of Plastic and Reconstructive Surgery, in accordance with the principles of the Declaration of Helsinki, and was approved by the Institutional Review Board. Written consent was obtained from the parents of the children for all acts of treatment. All authors acknowledge the content of the submitted manuscript and guarantee the accuracy and completeness of the data.
(© 2025. The Author(s).)

Indian J Otolaryngol Head Neck Surg. 2021 Jun;73(2):167-173. (PMID: 34150591)
N Y State Dent J. 2013 Jun-Jul;79(4):55-7. (PMID: 24027901)
Int J Dermatol. 2019 Jun;58(6):642-648. (PMID: 30345507)
J Craniofac Surg. 2016 Jul;27(5):e433-5. (PMID: 27258719)
J Plast Reconstr Aesthet Surg. 2007;60(9):1030-5. (PMID: 17478135)
Dermatol Surg. 2012 Jun;38(6):918-23. (PMID: 22272571)
Int J Dent. 2022 Sep 17;2022:8269221. (PMID: 36164597)
Laser Ther. 2018 Mar 31;27(1):61-64. (PMID: 29795973)
Dermatol Surg. 2010 Jul;36(7):1148-52. (PMID: 20533938)
Clin Oral Investig. 2021 Apr;25(4):1767-1774. (PMID: 32748074)
Dermatol Surg. 2001 Jun;27(6):521-3. (PMID: 11442586)
Facial Plast Surg Aesthet Med. 2021 Jul-Aug;23(4):289-293. (PMID: 32856950)
J Dermatolog Treat. 2006;17(4):247-9. (PMID: 16971323)
J Craniofac Surg. 2017 Nov;28(8):2068-2072. (PMID: 29019819)
J Stomatol Oral Maxillofac Surg. 2020 Jun;121(3):305-307. (PMID: 31163265)
Pediatr Dermatol. 1991 Dec;8(4):267-76. (PMID: 1792196)
J Fr Ophtalmol. 2023 Sep;46(7):e230-e233. (PMID: 37442691)
J Cosmet Laser Ther. 2014 Aug;16(4):197-200. (PMID: 24689434)
J Stomatol Oral Maxillofac Surg. 2021 Jun;122(3):267-272. (PMID: 32622002)
Ann Vasc Surg. 2014 Aug;28(6):1564.e9-14. (PMID: 24509379)
J Dermatol Sci. 2011 Sep;63(3):139-47. (PMID: 21664109)
J Laryngol Otol. 2011 Sep;125(9):973-7. (PMID: 21745433)
J Oral Sci. 2006 Dec;48(4):167-75. (PMID: 17220613)
J Cutan Aesthet Surg. 2022 Jul-Sep;15(3):284-287. (PMID: 36561400)
J Indian Soc Periodontol. 2021 Mar-Apr;25(2):162-165. (PMID: 33888950)
Gastrointest Endosc. 2007 Jul;66(1):1-6. (PMID: 17591465)
J Clin Diagn Res. 2016 Jan;10(1):ZD13-4. (PMID: 26894188)
Medicine (Baltimore). 2020 Feb;99(9):e18839. (PMID: 32118707)
Dermatol Surg. 2022 Jan 1;48(1):72-75. (PMID: 34816819)
Med Oral Patol Oral Cir Bucal. 2018 Mar 1;23(2):e180-e187. (PMID: 29476682)
Case Rep Dent. 2023 Oct 11;2023:5583749. (PMID: 37869522)
Dermatol Surg. 2010 Jun;36 Suppl 2:1068-70. (PMID: 20590716)
Dermatol Surg. 2021 Jun 1;47(6):802-804. (PMID: 33625133)
Lasers Surg Med. 2022 Aug;54(6):835-840. (PMID: 35395702)
J Clin Laser Med Surg. 1994 Aug;12(4):225-9. (PMID: 10147482)
Lasers Med Sci. 2020 Sep;35(7):1589-1597. (PMID: 32277406)
Lasers Med Sci. 2019 Feb;34(1):41-45. (PMID: 29998355)
Ann Vasc Surg. 2014 Jul;28(5):1335-49. (PMID: 24509373)
Acta Med Port. 2016 Jun;29(6):416. (PMID: 27865223)
Odontology. 2023 Apr;111(2):511-521. (PMID: 36307616)
Indian J Dermatol Venereol Leprol. 2022 May-Jun;88(4):500-508. (PMID: 34672473)
Indian J Dermatol Venereol Leprol. 2011 May-Jun;77(3):349-68. (PMID: 21508585)
J Plast Reconstr Aesthet Surg. 2010 Aug;63(8):1364-8. (PMID: 19625228)
Forensic Sci Int. 2002 Dec 4;130(2-3):90-6. (PMID: 12477628)

Keywords: 1064 nm Nd:YAG laser; Children; Pyogenic granuloma; Sclerotherapy

Date Created: 20250122 Date Completed: 20250122 Latest Revision: 20250129

20250129

PMC11754835

10.1038/s41598-025-85401-8

39843523